HK1162467A1 - Method for producing diamine derivative - Google Patents

Method for producing diamine derivative

Info

Publication number
HK1162467A1
HK1162467A1 HK12102504.1A HK12102504A HK1162467A1 HK 1162467 A1 HK1162467 A1 HK 1162467A1 HK 12102504 A HK12102504 A HK 12102504A HK 1162467 A1 HK1162467 A1 HK 1162467A1
Authority
HK
Hong Kong
Prior art keywords
diamine derivative
producing diamine
producing
derivative
diamine
Prior art date
Application number
HK12102504.1A
Other languages
English (en)
Inventor
Takeo Koyama
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of HK1162467A1 publication Critical patent/HK1162467A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01Sulfonic acids
    • C07C309/28Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/29Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
    • C07C309/30Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings of six-membered aromatic rings substituted by alkyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK12102504.1A 2008-12-17 2012-03-13 Method for producing diamine derivative HK1162467A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008320693 2008-12-17
PCT/JP2009/070874 WO2010071121A1 (ja) 2008-12-17 2009-12-15 ジアミン誘導体の製造方法

Publications (1)

Publication Number Publication Date
HK1162467A1 true HK1162467A1 (en) 2012-08-31

Family

ID=42268792

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12102504.1A HK1162467A1 (en) 2008-12-17 2012-03-13 Method for producing diamine derivative

Country Status (18)

Country Link
US (1) US8404847B2 (de)
EP (1) EP2371830B1 (de)
JP (1) JP5305421B2 (de)
KR (1) KR101463653B1 (de)
CN (1) CN102256984B (de)
BR (1) BRPI0923109A8 (de)
CA (1) CA2747427C (de)
EG (1) EG26766A (de)
ES (1) ES2437346T3 (de)
HK (1) HK1162467A1 (de)
HR (1) HRP20131109T1 (de)
IL (1) IL213614A (de)
MY (1) MY150973A (de)
RU (1) RU2464271C1 (de)
SI (1) SI2371830T1 (de)
TW (1) TWI439464B (de)
WO (1) WO2010071121A1 (de)
ZA (1) ZA201104236B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2644803T5 (es) 2007-03-29 2024-02-26 Daiichi Sankyo Co Ltd Composición farmacéutica
EP2407457B1 (de) * 2009-03-10 2015-04-22 Daiichi Sankyo Company, Limited Verfahren zur herstellung eines diaminderivats
WO2010104106A1 (ja) 2009-03-13 2010-09-16 第一三共株式会社 光学活性なジアミン誘導体の製造方法
JP5692873B2 (ja) * 2010-03-19 2015-04-01 第一三共株式会社 ジアミン誘導体の結晶およびその製造方法
WO2015129603A1 (ja) * 2014-02-25 2015-09-03 第一三共株式会社 活性化血液凝固第X因子(FXa)阻害剤の高純度結晶
CN105777779B (zh) * 2014-12-16 2019-03-26 四川海思科制药有限公司 一种对甲苯磺酸依度沙班化合物
EP3318568A1 (de) 2016-11-04 2018-05-09 Esteve Química, S.A. Herstellungsverfahren für edoxaban-tosylat-monohydrat
KR102480897B1 (ko) * 2019-09-09 2022-12-23 주식회사 종근당 디아민 유도체의 제조방법
KR20220014858A (ko) 2020-07-29 2022-02-07 주식회사 종근당 디아민 유도체의 결정형 및 이의 제조 방법
CN114349770B (zh) * 2020-10-13 2023-02-03 江苏威凯尔医药科技有限公司 一种凝血FXa抑制剂的制备方法
KR102577696B1 (ko) 2020-11-16 2023-09-14 주식회사 보령 에독사반 토실산염 또는 그 수화물의 제조방법

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5149855A (en) 1989-12-26 1992-09-22 Mitsubishi Rayon Co., Ltd. Process for racemizing optically active carboxylic acid esters
US5055600A (en) 1990-04-24 1991-10-08 Rockwell International Corporation Glycidyl azide polymer (gap) synthesis by molten salt method
US5677469A (en) 1995-05-18 1997-10-14 Sepracor, Inc. Process for resolving chiral acids with 1-aminoindan-2-ols
JPH11180899A (ja) 1997-12-15 1999-07-06 Mitsui Chem Inc 活性メチレンアルキル化化合物の製造法
JP3680203B2 (ja) 1999-06-01 2005-08-10 東洋化成工業株式会社 4−アセチルアミノベンゼンスルホニルアジドの製造方法
JP2001151724A (ja) 1999-11-19 2001-06-05 Kuraray Co Ltd 光学活性な2,2,4−トリメチル−3−シクロヘキセンカルボン酸の製造方法
TWI290136B (en) 2000-04-05 2007-11-21 Daiichi Seiyaku Co Ethylenediamine derivatives
US7365205B2 (en) 2001-06-20 2008-04-29 Daiichi Sankyo Company, Limited Diamine derivatives
EP1405852B9 (de) 2001-06-20 2013-03-27 Daiichi Sankyo Company, Limited Diaminderivate
CN100545160C (zh) * 2001-08-09 2009-09-30 第一制药株式会社 二胺衍生物
KR20050110612A (ko) 2002-12-25 2005-11-23 다이이찌 세이야꾸 가부시기가이샤 디아민 유도체
HUE028247T2 (en) 2003-04-08 2016-12-28 Novartis Ag A solid oral composition comprising S1P receptor agonist and sugar alcohol
KR101170179B1 (ko) 2003-11-12 2012-07-31 다이이찌 산쿄 가부시키가이샤 티아졸 유도체의 제조법
AR057035A1 (es) 2005-05-25 2007-11-14 Progenics Pharm Inc SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
CA2621640C (en) * 2005-09-16 2013-10-29 Daiichi Sankyo Company, Limited Optically active diamine derivative and process for producing the same
JP4227629B2 (ja) 2006-04-28 2009-02-18 達實 小野 過熱蒸気を応用した塗装用乾燥焼付装置
WO2008043996A2 (en) 2006-10-09 2008-04-17 Cipla Limited Process for preparing trityl olmesartan medoxomil and olmesartan medoxomil
ES2644803T5 (es) 2007-03-29 2024-02-26 Daiichi Sankyo Co Ltd Composición farmacéutica
TW200909437A (en) 2007-06-21 2009-03-01 Daiichi Sankyo Co Ltd Process for the preparation of diamine-derivatives

Also Published As

Publication number Publication date
US20110275821A1 (en) 2011-11-10
IL213614A0 (en) 2011-07-31
BRPI0923109A2 (pt) 2016-02-02
ES2437346T3 (es) 2014-01-10
KR101463653B1 (ko) 2014-11-19
WO2010071121A1 (ja) 2010-06-24
EP2371830B1 (de) 2013-10-02
TW201028428A (en) 2010-08-01
MY150973A (en) 2014-03-31
CA2747427C (en) 2015-10-13
KR20110110100A (ko) 2011-10-06
CN102256984A (zh) 2011-11-23
SI2371830T1 (sl) 2014-01-31
JP5305421B2 (ja) 2013-10-02
RU2464271C1 (ru) 2012-10-20
TWI439464B (zh) 2014-06-01
EG26766A (en) 2014-08-18
EP2371830A1 (de) 2011-10-05
BRPI0923109A8 (pt) 2016-06-07
ZA201104236B (en) 2012-02-29
JPWO2010071121A1 (ja) 2012-05-31
IL213614A (en) 2015-10-29
CN102256984B (zh) 2014-09-03
EP2371830A4 (de) 2012-07-11
CA2747427A1 (en) 2010-06-24
US8404847B2 (en) 2013-03-26
HRP20131109T1 (hr) 2014-01-31

Similar Documents

Publication Publication Date Title
IL211128A0 (en) Method for producing amide derivative
EP2407457A4 (de) Verfahren zur herstellung eines diaminderivats
EP2303885A4 (de) Verfahren zur herstellung von bicycloanilinderivaten
EP2332424A4 (de) Verfahren zur lipidherstellung
ZA201009116B (en) Method for producing microlenses
HK1162467A1 (en) Method for producing diamine derivative
PL2252691T3 (pl) Sposób otrzymywania alfa-santalenu
PL2160432T3 (pl) Sposób wytwarzania poliamidów
EP2407450A4 (de) Verfahren zur herstellung eines optisch aktiven diaminderivats
HK1156644A1 (en) Method for producing polyamide
PL2307356T3 (pl) Sposób wytwarzania izocyjanianów
PT2373616E (pt) Processo para a produção de isocianatos
EP2309823A4 (de) Verfahren zur geräteherstellung
PT2367783E (pt) Processo para a produção de um isocianato
EP2332421A4 (de) Verfahren zur herstellung modifizierter milch
PL2349986T3 (pl) Sposób wytwarzania izocyjanianów
EP2374789A4 (de) Verfahren zur herstellung von beta-alkoxypropionamid
EP2221306A4 (de) Verfahren zur herstellung von 2-azaadamantan
PT2288591E (pt) Método para a produção de difenilmetano diamina
IL210051A0 (en) Method for producing aminobiphenylene
EP2357247A4 (de) Verfahren zur herstellung von poly-3-hydroxyalkanoat
EP2259269A4 (de) Verfahren zur herstellung von radiostrontium
EP2305649A4 (de) Verfahren zur herstellung eines 6-aryloxychinolin-derivats und eines zwischenprodukts davon
EP2248810A4 (de) Verfahren zur herstellung eines phenoxypyridin-derivats
IL210353A0 (en) Method for producing phenylalkane - 1 - ols